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This study was carried out to investigate the epidemiological time-course of
New Delhi metallo-beta-lactamase- (NDM-) mediated carbapenem resistance in
Enterobacteriaceae in South Korea. A total of 146 non-duplicate NDM-producing
Enterobacteriaceae recovered between 2010 and 2015 were voluntarily collected from
33 general hospitals and confirmed by PCR. The species were identified by sequences
of the 16S rDNA. Antimicrobial susceptibility was determined either by the disk diffusion
method or by broth microdilution, and the carbapenem MICs were determined by agar
dilution. Then, multilocus sequence typing and PCR-based replicon typing was carried
out. Co-carried genes for drug resistance were identified by PCR and sequencing. The
entire genomes of eight random selected NDM producers were sequenced. A total
of 69 Klebsiella pneumoniae of 12 sequence types (STs), 34 Escherichia coli of 15
STs, 28 Enterobacter spp. (including one Enterobacter aerogenes), nine Citrobacter
freundii, four Raoultella spp., and two Klebsiella oxytoca isolates produced either NDM-1
(n = 126), NDM-5 (n = 18), or NDM-7 (n = 2). The isolates co-produced CTX-M-type
ESBL (52.1%), AmpCs (27.4%), additional carbapenemases (7.1%), and/or 16S rRNA
methyltransferases (4.8%), resulting in multidrug-resistance (47.9%) or extensively
drug-resistance (52.1%). Among plasmids harboring blaNDM, IncX3 was predominant
(77.4%), followed by the IncFII type (5.8%). Genome analysis revealed inter-species and
inter-strain horizontal gene transfer of the plasmid. Both clonal dissemination and plasmid
transfer contributed to the wide dissemination of NDM producers in South Korea.
Keywords: New Delhi metallo-beta-lactamase, carbapenemase-producing Enterobacteriaceae, IncX3, IncFII,
Tn125
INTRODUCTION
The first New Delhi metallo-beta-lactamase (MBL), NDM-1, was identified in 2008 in an
extensively drug-resistant (XDR) Klebsiella pneumoniae clinical isolate recovered from a urinary
specimen of a patient (Yong et al., 2009). The enzyme had an astonishing range of beta-
lactam substrates, including penicillins, late-generation cephalosporins, and carbapenems with the
exception of monobactams (Yong et al., 2009). The coding gene was found to be located in a
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∼180-kb plasmid that is readily transferable by conjugation
(Yong et al., 2009). Further epidemiology revealed that the
gene had already spread to various species of bacteria including
K. pneumoniae, Escherichia coli, Enterobacter spp., Morganella
morganii, and Acinetobacter baumannii throughout the six
continents (Johnson and Woodford, 2013), implying that the
plasmid encoding NDM has an enormous ability to spread.
Since the identification of the first NDM variant (NDM-2)
in A. baumannii (Kaase et al., 2011), 17 subtypes of NDM
variants have been functionally characterized (Liu et al., 2017).
The NDM subtypes, which differ from the NDM-1 prototype
by one to five amino-acid substitutions, exhibit different levels
of hydrolyzing activity against carbapenems and other beta-
lactam substrates, depending on the substitutions. Among
the first seven subtypes, NDM-7 containing two substitutions
of Asp130Asn and Met154Leu has the greatest carbapenem-
hydrolyzing activity, followed by NDM-5 with Val88Leu and
Met154Leu, NDM-6 with Ala233Val, andNDM-1 (Rahman et al.,
2014).
The blaNDM gene has been found in plasmids of diverse
replicon types, such as IncF, IncX3, IncL/M, IncH, and IncA/C,
and has an extensive host range. In plasmids, the gene is
frequently associated with mobile genetic elements such as
transposons and insertion sequences (ISs). The complete form
of the transposable element of the blaNDM gene Tn125 was
first identified in A. baumannii, suggesting that Acinetobacter
spp. are the reservoir of the gene (Poirel et al., 2012). Tn125
is bracketed by two copies of ISAba125. One copy of ISAba125
is located upstream of the blaNDM gene, and the bleMBL gene
encoding resistance to the anti-tumor glycopeptide bleomycin is
at 3′ end of the gene, followed by eight ORFs and the 3′ copy
of ISAba125. The composite form of the transposon is common
in A. baumannii, and at least in this species, the mobility of
the blaNDM gene is mainly attributed to the transposon (Poirel
et al., 2012). Unlike in A. baumannii, the Tn125 transposon
of Enterobacteriaceae is in a truncated form that is no longer
mobile. This indicates that plasmids are important for blaNDM
mobility among Enterobacteriaceae (Partridge and Iredell, 2012).
To monitor the spread of carbapenemase-producing
Enterobacteriaceae (CPE), the Korea Center for Disease
Prevention and Control (KCDC) had run a national surveillance
system since 2010. In this study, the NDM producers collected
from this surveillance system between 2010 and 2015 were
investigated for the epidemiological time-course of NDM-
mediated carbapenem resistance by analyzing the clones,
plasmids, and genetic contexts of the blaNDM gene. In order
to evaluate the inter-species and inter-strain horizontal gene
transfer, WGS was performed to characterize the main mobile
genetic elements responsible for NDM dissemination.
MATERIALS AND METHODS
Bacterial Strains
During the period between 2010 and 2015, 146 non-duplicate
NDM producers were voluntarily collected from 33 general
hospitals composing the National Laboratory Surveillance
System for carbapenemase-producing Enterobacteriaceae (CPE)
of the Korea Center for Disease Prevention and Control. Further
testing including the species identification by using Bruker
MALDI MS instrument (Bruker, Billerica, MA, USA) and by 16S
rDNA sequencing was performed in a reference laboratory.
Antimicrobial Susceptibility Testing and
Resistance Genotyping
Antimicrobial susceptibility to eight drugs (aztreonam,
cefotaxime, ceftazidime, cefoxitin, gentamicin, amikacin,
ciprofloxacin, and tigecycline) was evaluated by the disk
diffusion method on Mueller-Hinton (MH) agar (Difco
Laboratories, Detroit, MI, USA) in accordance with CLSI
guidelines (CLSI, 2015b). The MICs for colistin were assessed
by the broth microdilution method with MH broth (Difco
Laboratories) in accordance with the recommendations of The
joint CLSI–EUCAST (2016). The MICs for imipenem and
meropenem were determined by the agar dilution method in
accordance with CLSI guidelines (CLSI, 2015a). Both E. coli
ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were
used for quality control. The blaNDM gene was detected by
PCR with gene-specific primers and direct sequencing was
carried out for NDM subtyping (Poirel et al., 2011). Genetic
contexts for the vicinity of the blaNDM gene were explored by
PCR mapping using primers in the supplemental figure. The
confirmed NDM producers were further evaluated by PCR
and by direct sequencing to identify the following additional
resistance determinants: blaOXA−48−like, blaIMP, blaVIM, and
blaGES for carbapenemases (Poirel et al., 2011); blaCTX−M−1−like,
blaCTX−M−9−like, and blaCTX−M−25−like for CTX-M-type
extended-spectrum-beta-lactamases (ESBLs); blaACT, blaACC,
blaCMY, and blaDHA for plasmid-mediated AmpCs; and
armA, rmtA, and rmtB for 16S ribosomal methyltransferases
(Pérez-Pérez and Hanson, 2002; Ryoo et al., 2005).
MLST
PCR and sequencing were carried out for seven housekeeping
genes per species: gapA, infB, mdh, pgi, phoE, rpoB, and tonB
for K. pneumoniae (Diancourt et al., 2005) and adk, fumC, gyrB,
icd, mdh, purA, and recA for E. coli (Wirth et al., 2006) and
the sequences were compared in the multilocus sequence typing
(MLST) database, so that allelic numbers and sequence types
(STs) could be determined.
Plasmid Transfer by Bacterial Conjugation
and Electroporation
For bacterial conjugation, spontaneous rifampin-resistant
mutants from E. coli J53 were used as recipients. Equal amounts
of exponential cultures of the donor and recipient isolates
were mixed, incubated in MH broth for 12 h, and spread
on Brain Heart Infusion (BHI) agar (Difco Laboratories)
containing rifampin (30 mg/L), sodium azide (100 mg/L), and
imipenem (1 mg/L). Each colony was tested by disk diffusion
test and confirmed by PCR. The plasmid transfer frequency
was calculated as the number of transconjugants per donor.
The non-conjugative plasmids were electrotransferred into One
ShotTM TOP10 ElectrocompTM E. coli (ThermoFisher Scientific,
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Waltham, MA, USA) following the manufacturer’s instruction
and selected on BHI supplemented with imipenem 4 mg/L.
Whole Genome Sequencing
Eight NDM producers were entirely sequenced: one Enterobacter
sp. with an IncX3 plasmid encoding NDM-1; four E. coli isolates
with IncX3 plasmids encoding any of NDM-1, −5, and −7;
one Citrobacter freundii with IncX3 plasmid encoding NDM-5;
two K. pneumoniae strains co-producing OXA-181 and NDM-
5 which the blaNDM−5 gene was carried by the IncFII plasmid.
Bacterial whole genomes were sequenced with single-molecule
real-time sequencing on a PacBio RSII instrument (Pacific
Biosciences, Menlo Park, CA, USA) as previously described
(Hong et al., 2016). De novo genome assembly was performed
with the PacBio SMRT analysis software suite (version 2.3.0) and
the annotations of coding sequences, tRNA sequences, and rRNA
sequences were performed using the NCBI Prokaryotic Genome
Annotation Pipeline.
GenBank Accession
The genomes of eight Enterobacteriaceae isolates are available
in the GenBank nucleotide database under the accession
numbers CP024812-CP024814 for Enterobacter sp. CRENT-
193, CP024815-CP024818 for E. coli CREC-629, CP024819-
CP024820 for C. freundii for CRCB-101, CP024821-CP024825
for E. coliCREC-591, CP024826-CP024829 for E. coliCREC-544,
CP024830-CP024833 for E. coliCREC-532, CP024834-CP024837
for K. pneumoniae CRKP-2297, and CP024838-CP024841 for K.
pneumoniae CRKP-1215 under the BioProject PRJNA416193.
RESULTS
Occurrence of NDM Producers Between
2010 and 2015
In 2010, four NDM-1-producing K. pneumoniae ST340 isolates
were identified in a single hospital outbreak in Seoul (Kim et al.,
2012). In 2011, five isolates of the same clone were successively
identified at the same hospital and one and three NDM-1-
producing E. coli ST101 isolates were identified at another
hospital in Seoul and at a hospital in the southeastern region
of the Korean peninsula, respectively. The NDM-1-producing
K. pneumoniae ST340 was identified in the central part of the
peninsula in 2012 and in 2013, diverse NDM-producing bacterial
pathogens such as C. freundii and Enterobacter spp. were
identified in a broader region, including the southern peninsula.
By 2014, the number of NDM producers had explosively
increased from eight to 22, with even more diverse bacterial
pathogens, including Klebsiella oxytoca and Raoultella planticola.
Finally, in 2015, among the 102 NDM producers identified over
the peninsula, NDM-5 and NDM-7 producers were identified.
Three of the 18 NDM-5 producers were previously reported as
NDM-5 and OXA-181 co-producer (Sun et al., 2016).
Characteristics of the NDM Producers
PCR and sequencing revealed that the 146 NDM-producing
Enterobacteriaceae isolates contained either blaNDM−1 (n = 126,
86.3%), blaNDM−5 (n = 18, 12.3%), or blaNDM−7 (n = 2, 1.4%).
The isolates included 69 K. pneumoniae (47.3%), 34 E. coli
(23.3%), 27 Enterobacter spp. (18.5%), two K. oxytoca (1.4%),
nine C. freundii (6.2%), three R. planticola (2.1%), and one
Raoultella ornithinolytica (0.7%), which were recovered from
urine (n= 57, 39.0%), pulmonary samples (n= 29, 19.9%), rectal
swabs (n= 22, 15.1%), body fluids (n= 15, 10.3%), blood (n= 7,
4.8%), wounds (n= 7, 4.8%), and others (n= 9, 6.2%).
MLST analysis revealed 12 K. pneumoniae STs for the 69
isolates: ST1061 (n = 20, 29.0%), ST340 (n = 10, 14.5%), ST147
(n= 9, 13.0%), ST14 (n= 8, 11.6%), ST307 (n= 7, 10.1%), ST11
(n = 6, 8.7%), ST2 (n = 4, 5.8%), and one each of ST631, ST70,
ST789, ST392, and ST2353. It also identified 15 E. coli STs for 34
isolates: ST101 (n = 15, 44.1%), ST167 (n = 3, 8.8%), ST410 (n
= 3, 8.8%), ST457 (n = 2, 5.9%), and one each of ST38, ST69,
ST88, ST90, ST118, ST354, ST361, ST362, ST1177, ST1284, and
ST1543. It is worth remarking that K. pneumoniae ST340, ST14,
ST147, and ST11, along with E. coli ST69, are prominent high-
risk clones known to be resistant tomultiple drugs (Mathers et al.,
2015). The group of 18 NDM-5 producers consisted of 14 E. coli
isolates (77.8%, nine ST101 and one each of ST162, ST361, ST362,
ST88, and ST90), threeK. pneumoniae isolates (16.7%, two ST147
and one ST392), and one C. freundii isolate (5.6%), while both
NDM-7 producers were E. coli ST167.
The isolates were all resistant to both carbapenems, having
MICs≥2 mg/L, except for one isolate that had MICs of 0.5 and 1
mg/L for imipenem and meropenem, respectively (Table 1). The
imipenem MIC50 and MIC90 were 16 and 64 mg/L, respectively,
and those of meropenem were 16 and 128 mg/L. Based on the
standard definitions for acquired resistance (Magiorakos et al.,
2012), all studiedNDMproducers were eithermultidrug resistant
(MDR; 70/146, 47.9%) or XDR (76/146, 52.1%) (Table 2). No
isolate was pan-drug-resistant, as they all remained susceptible
to tigecycline or colistin. Ciprofloxacin was the most co-resistant
antibiotic (122/146, 83.6%), followed by aztreonam (107/146,
73.3%), even though NDM does not hydrolyze monobactams.
The high rate of co-resistance was well-explained by co-
harbored genes for antimicrobial resistance (Table 3). Among
the NDM producers, 62.3% (91/146) and 39.0% (57/146)
harbored at least one gene for ESBL or for plasmid-mediated
AmpC, respectively. In addition, 7.5% (11/146) carried another
carbapenemase gene and 32.2% (47/146) possessed a gene for 16S
rRNA methyltransferase. Most of the NDM-5 producers (15/18)
co-produced CTX-M group 1 ESBL and both NDM-7 producers
co-produced the CTX-M group 9 ESBL.
The blaNDM-Carrying Plasmids
PCR-based replicon typing (Carattoli et al., 2005) after
conjugation or electroporation allowed us to scrutinize the
bacterial dissemination of plasmids belonging to four different
incompatibility types: IncFII (n = 9, 5.8%), IncX3 (n = 113,
77.4%), IncA/C (n = 5, 3.4%), and non-typeable (n = 19,
13.0%). Among these plasmids, only IncX3 was carried by diverse
bacterial species including K. pneumoniae, E. coli, Enterobacter
spp.,K. oxytoca, andC. freundii, highlighting its broad host range.
The blaNDM−1 gene was carried by all four types of plasmids,
while blaNDM−5 was carried by either IncFII or IncX3 plasmids,
and blaNDM−7 was carried by the IncX3 plasmid.
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TABLE 1 | Distribution of carbapenem MICs in NDM producers by subtype.
Number (cumulative %) of isolates having MICs (mg/L) ofa:
0.5 1 2 4 8 16 32 64 128 >128
IMIPENEM
All NDM producers (n = 146) 1 (0.7) 0 (0.7) 2 (2.1) 13 (11.0) 34 (34.2) 45 (65.1) 26 (82.9) 15 (93.2) 5 (96.6) 5 (100)
NDM-1 producers (n = 126) 1 (0.8) 0 (0.8) 2 (2.4) 13 (12.7) 34 (39.7) 37 (69.0) 19 (84.1) 13 (94.4) 2 (96.0) 5 (100)
NDM-5 producers (n = 18) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 7 (38.9) 7 (77.8) 2 (88.9) 2 (100) 0 (100)
NDM-7 producers (n = 2) 0 0 0 0 0 1 0 0 1 0
MEROPENEM
All NDM producers (n = 146) 0 (0.0) 1 (0.7) 3 (2.7) 9 (8.9) 33 (31.5) 34 (54.8) 31 (76.0) 13 (84.9) 16 (95.9) 6 (100)
NDM-1 producers (n = 126) 0 (0.0) 1 (0.8) 3 (3.2) 9 (10.3) 31 (34.9) 33 (61.1) 23 (79.4) 11 (88.1) 11 (96.8) 4 (100)
NDM-5 producers (n = 18) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (11.1) 1 (16.7) 7 (55.6) 2 (66.7) 5 (94.4) 1 (100)
NDM-7 producers (n = 2) 0 0 0 0 0 0 1 0 0 1
aMIC50 and MIC90 are indicated in bold.
TABLE 2 | Antibiograms of NDM producers by subtype.
MDR (%) XDR (%) PDR (%) Number (%) of isolates non-susceptible to:
CIP GM AN ATM CTX CAZ FOX TGC COL
All NDM producers (n = 146) 70 (47.9) 76 (52.1) 0 (0) 122 (83.6) 86 (58.9) 61 (41.8) 107 (73.3) 146 (100) 146 (100) 146 (100) 9 (6.2) 13 (8.9)
NDM-1 producers (n = 126) 56 (44.4) 70 (55.6) 0 (0) 104 (82.5) 78 (61.9) 57 (45.2) 91 (72.2) 126 (100) 126 (100) 126 (100) 8 (6.3) 12 (9.5)
NDM-5 producers (n = 18) 14 (77.8) 4 (22.2) 0 (0) 16 (88.9) 6 (33.3) 4 (22.2) 14 (77.8) 18 (100) 18 (100) 18 (100) 1 (5.6) 1 (5.6)
NDM-7 producers (n = 2) 0 (0.0) 2 (100) 0 (0) 2 (100) 2 (100) 0 (0.0) 2 (100) 2 (100) 2 (100) 2 (100) 0 (0.0) 0 (0.0)
MDR, Multidrug-resistant; XDR, extensively drug-resistant; PDR, pan-drug-resistant; CIP, ciprofloxacin; GM, gentamicin; AN, amikacin; ATM, aztreonam; CTX, cefotaxime; CAZ,
ceftazidime; FOX, cefoxitin; TGC, tigecycline; COL, colistin.
By liquid mating, plasmid transfer was detected in only one
third (29.5%, 43/146) of the plasmids with various conjugation
efficiencies (from 5 × 10−5 to 5 × 10−8) and the rest (70.5%,
103/146) presented plasmid transfer frequencies under the
detection threshold (<1× 10−9). Plasmids belonging to the same
incompatibility type resulted in varied rate of plasmid transfer:
28.3% (32/113) of IncX3 plasmids had transfer frequencies of 1×
10−6 to 1× 10−8, while 71.7% (81/113) of those presented below
the detection threshold; two of the six (33.3%) IncFII plasmids
had transfer rates either of 5 × 10−5 or 3 × 10−7 and the other
four (66.7%) presented below the detection threshold; and one of
the five (20%) IncA/C plasmids had plasmid transfer frequency
of 1× 10−5 and the other four had undeterminable rate.
Since the genetic environment of the blaNDM gene is diverse
in terms of size and Tn125 truncation, the vicinity of the gene
was evaluated by PCR mapping. For the upstream region of the
gene, all plasmids had a promoter region located at the 72-bp
extremity of ISAba125. One exceptional case having imipenem
and meropenem MICs of 16 and 32 mg/L, respectively, carried
a relatively short IS125 remnant at the upstream of the blaNDM
gene, remaining the promoter sequences. Downstream of the
gene, 17 cases of truncated Tn125 ended with the groEL gene (the
6th ORF from blaNDM among eight) and thus themost preserved,
whereas one case ended with bleMBL next to the blaNDM gene (the
most shrunken case). Around half of the cases (n = 66, 45.2%)
ended with the tat gene, the 4th ORF from the blaNDM gene,
while 34.2% (n= 50) terminated with trpF, the 2ndORF from the
gene. The Tn125 transposons carrying blaNDM−1 were truncated
at heterogeneous sites along the transposon, while those carrying
blaNDM−7 ceased at the tat gene and those carrying blaNDM−5
were truncated at the end of either tat or trpF. No obvious
correlation was observed between carbapenem susceptibility and
the Tn125 truncation locus.
IncX3 Plasmids Carrying Three Subtypes
of blaNDM and IncFII Plasmids Carrying
blaNDM-5
As the IncX3 plasmids were the most common among NDM
producers, regardless of the NDM subtype or bacterial host,
we completely sequenced a panel of six NDM producers that
possessed IncX3 plasmids carrying any of three NDM subtypes
(Figure 1, Table 4). Two OXA-181 and NDM-5 co-producers
in which the blaNDM−5 gene was carried by the IncFII plasmid
were added to the panel for comparative analysis. The eight
isolates exhibited MDR or XDR resistance phenotypes (Figure 1,
Table 4). The Enterobacter sp. CRENT-193 was an isolate in
2013, while K. pneumoniae CRKP-1215 was in 2014, and the
remaining six were in 2015 (Table 4). Three isolates (Enterobacter
sp. CRENT-193, K. pneumoniae CRKP-1215, and CRKP-2297)
were from Seoul, among which both K. pneumoniae isolates co-
producing OXA-181 and NDM-5 were from one hospital with
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TABLE 3 | Co-harbored antimicrobial resistance genes in NDM producers.
NDM-1 NDM-5 NDM-7 Total
(n = 126) (n = 18) (n = 2) (n = 146)
CTX-M-TYPE EXTENDED-SPECTRUM BETA-LACTAMASE
CTX-M group 1 53 (42.1) 13 (72.2) 0 (0.0) 66 (45.2)
blaCTX−M−15 26 (20.6) 13 (72.2) 0 (0.0) 39 (26.7)
blaCTX−M−22 2 (1.6) 0 (0.0) 0 (0.0) 2 (1.4)
blaCTX−M−28 19 (15.1) 0 (0.0) 0 (0.0) 19 (13.0)
blaCTX−M−3 3 (2.4) 0 (0.0) 0 (0.0) 3 (2.1)
blaCTX−M−55 3 (2.4) 0 (0.0) 0 (0.0) 3 (2.1)
CTX-M group 9 7 (5.6) 1 (5.6) 1 (50.0) 9 (6.2)
blaCTX−M−9 3 (2.4) 0 (0.0) 0 (0.0) 3 (2.1)
blaCTX−M−14 3 (2.4) 1 (5.6) 1 (50.0) 5 (3.4)
blaCTX−M−27 1 (0.8) 0 (0.0) 0 (0.0) 1 (0.7)
Group 1 and group 9 0 (0.0) 0 (0.0) 1 (50.0) 1 (0.7)
blaCTX−M−55 / blaCTX−M−14 0 (0.0) 0 (0.0) 1 (50.0) 1 (0.7)
PLASMID-MEDIATED AmpC
ACT type 2 (1.6) 0 (0.0) 0 (0.0) 2 (1.4)
blaACT−1 2 (1.6) 0 (0.0) 0 (0.0) 2 (1.4)
CMY type 8 (6.3) 1 (5.6) 0 (0.0) 9 (6.2)
blaCMY−2 5 (4.0) 1 (5.6) 0 (0.0) 6 (4.1)
blaCMY−42 1 (0.8) 0 (0.0) 0 (0.0) 1 (0.7)
blaCMY−48 1 (0.8) 0 (0.0) 0 (0.0) 1 (0.7)
blaCMY−64 1 (0.8) 0 (0.0) 0 (0.0) 1 (0.7)
DHA type 25 (19.8) 0 (0.0) 0 (0.0) 25 (17.1)
blaDHA−1 25 (19.8) 0 (0.0) 0 (0.0) 25 (17.1)
CMY type and DHA type 4 (3.2) 0 (0.0) 0 (0.0) 4 (2.7)
blaCMY−4 / blaDHA−1 4 (3.2) 0 (0.0) 0 (0.0) 4 (2.7)
CARBAPENEMASES
blaKPC−2 3 (2.4) 0 (0.0) 0 (0.0) 3 (2.1)
blaKPC−4 1 (0.8) 0 (0.0) 0 (0.0) 1 (0.7)
blaOXA−181 0 (0.0) 2 (11.1) 0 (0.0) 2 (2.7)
blaOXA−232 3 (2.4) 1 (5.6) 0 (0.0) 4 (2.7)
blaVIM−2 1 (0.8) 0 (0.0) 0 (0.0) 1 (0.7)
16S rRNA METHYLTRANSFERASE
armA 41 (32.5) 3 (16.7) 0 (0.0) 44 (30.1)
rmtC 2 (1.6) 0 (0.0) 0 (0.0) 2 (1.4)
rmtF 0 (0.0) 1 (5.6) 0 (0.0) 1 (0.7)
one-year interval. Two E. coli isolates (CREC-544 and CREC-
591) and C. freundii CRCB-101 were from Incheon, a suburb of
Seoul, among which E. coli CREC-591 and C. freundii CRCB-
101 were from a single hospital outbreak. The remaining E.
coli CREC-532 and CREC-629 isolates were recovered in the
southwestern and southeastern peninsula, respectively.
The IncX3 plasmids harboring blaNDM−5 or blaNDM−7 had
consistent sizes of 46,137 and 46,161 bp, respectively, whereas
the two plasmids harboring the blaNDM−1 gene were 44,962- and
51,455-bp long. The six IncX3 plasmids had conserved backbones
including elements of conjugal transfer, the replication origin,
and other accessory genes. The differing lengths of the plasmids
were due to the excision of a 1,175-bp 1IS5 copy upstream
of the truncated Tn125 in pCRENT-193_3 and the insertion
of a 5,294-bp fragment including blaSHV−12 in pCREC-544_2
(Figure 1). Of note, the plasmids pCREC-591_4 and pCRCB-
101_1, which were identified from different pathogenic species
(E. coli ST101 and C. freundii) in a single hospital outbreak, were
identical, clarifying the inter-species transfer of the plasmid. The
six isolates possessed various resistance determinants in their
chromosomes. Interestingly, CTX-M-type ESBLs and plasmid-
mediated AmpCs, which are known to be more common in
plasmids than in the chromosome, were frequently encoded in
the chromosome (Table 4). Further, except for C. freundii CRCB-
101, all isolates co-carried additional plasmids with multiple
genes for drug resistance (Table 4).
Both IncFII plasmids (pCRKP-1215_2 and pCRKP-2297_2)
from K. pneumoniae ST147 isolates recovered at a hospital were
identical, even they were identified one year apart. The co-
produced OXA-181 was encoded in the chromosome by two
copies of blaOXA−181 and the chromosomes of the two isolates
were very similar to each other, sharing 99% nt identity on 100%
coverage. Taken together, these results clearly demonstrate the
persistence of the clone in the clinical setting. The IncFII plasmid
itself conferred MDR, due to the aadA3, dfrA23, and sul1 genes
associated with the class 1 integron, the blaTEM−1B accompanied
by Tn3, and the erm(B), mph(A), and rmtB genes (Figure 1 and
Table 4). A set of three plasmids (two different IncFII and one
non-typeable) was carried together by the isolates.
DISCUSSION
The epidemiology of NDM-mediated carbapenem resistance is
complex because the dissemination involves multiple factors,
such as the clonal spread of resistant strains and the inter-
strain and inter-species horizontal transfer of the resistance
determinants. The global NDMproducers include diverse species
and genera within Gram-negative bacteria and a wide range of
clones within individual species, as indicated by ST. The NDM-
encoding plasmids and the mobile elements of the blaNDM gene
are also complicated in South Korea depend on the bacterial
species and the strains. The mobility of the plasmid is critical for
the dissemination of blaNDM. NDM-producing clones possessing
a transferable plasmid with blaNDM have been demonstrated to
spread blaNDM efficiently, while a non-conjugative plasmid is
reliable for clonal spread (Kumarasamy et al., 2010).
Until 2012, the occurrence of NDM producers in South
Korea was regionally restricted and the constituents were simple.
Beginning in 2013, the NDM producers became diverse at the
species level and in 2014, a range of varied clones began to
be identified within individual species. Finally, in 2015, two
additional NDM variants were recognized within even more
diverse bacterial hosts. Thus, the population of NDM producers
in South Korea achieved the epidemiological complexity and
diversity as worldwide NDM population. The IncX3 plasmid
carrying the blaNDM gene, which is either transferable or non-
mobile, was likely responsible for the dissemination of NDM
producers over the peninsula.
The six circularized IncX3 plasmids had a relatively simple
structure composed of conjugal transfer elements, accessory
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FIGURE 1 | Schematic representation of the blaNDM-harboring IncX3 and IncFII plasmids. Name of the plasmids and the size in parenthesis are denoted for the
plasmids, and the district of isolation are indicated on the map of Korean peninsula in front of the plasmid name. Name of the plasmids from E. coli are indicated in
black, from Enterobacter spp. in blue, and from K. pneumoniae in red. Open arrows indicate coding sequences for conjugal transfer (light green), drug resistance (red),
replication origin (blue), toxin/antitoxin system (black), transposase (yellow), and integrase (green). Insertion sequences are indicated in yellow boxes. The Tn125 is
marked with a red-bordered open box, and the class 1 integron is indicated with a green-bordered open box. Genetic variants of each plasmid referred by
pCREC-629_3 are indicated on the right side of the schematic representation of the plasmid for locating the point of substitution: arrowheads, deletion; square
bracket, insertion. Together with the nt substitutions, details of insertion are indicated with +, and that of deletion with 1 in the end of the schematic presentation of
the plasmid.
genes, and a single resistance determinant (blaNDM). Only
one IncX3 plasmid possessed one blaSHV−12 gene in addition
to the blaNDM gene. The IncX3 plasmids identified in
this study were identical to those from the Middle East,
which is a recently added reservoir of NDM producers
(Zowawi et al., 2013). This simple plasmid, in terms of
resistance gene carriages, has a broad host range, which
greatly enhances its inter-genera and inter-species dissemination.
Actually, in our collection of isolates, more than three-
quarters of the blaNDM-possessing plasmids were IncX3 type
and were carried by varied clones of various species of
bacteria.
All NDM producers were resistant to more than three classes
of antimicrobial drugs. Further, the NDM producers, especially
those possessing the IncX3-type blaNDM plasmid, were vested
in MDR, either due to supplemental plasmid(s) containing
several genes for antimicrobial resistance, as we observed in this
study, or due to the hybridization of plasmids with additional
resistance genes (Sun et al., 2016). The IncA/C- and IncFII-
type plasmids were kept within E. coli and K. pneumoniae
bacterial hosts, though they are known to have broad host
ranges; thus, their spreads were limited both temporally and
regionally.
The NDM-5 andNDM-7 producers, even with relatively small
numbers of isolates, had higher carbapenem MICs than the
NDM-1 producers (Table 1). These subtypes share a substitution
of Methionine to Leucine at position 154, identical to that in
NDM-4 (Nordmann et al., 2012), and have greater MICs than
NDM-1, not only for carbapenems, but also for 3rd- and 4th-
generation cephalosporins such as cefotaxime, ceftazidime, and
cefpirome (Hornsey et al., 2011). Additionally, as shown by
both entirely sequenced co-producers, co-production of OXA-
181 with NDM-5, could contribute to elevate the carbapenem
MICs. Notably, the blaNDM−5 gene, which was observed in both
IncX3 and IncFII plasmids, was initially identified in an IncF-type
plasmid possessed by E. coli ST648 (Hornsey et al., 2011). And the
blaNDM−7 gene, which was identified only in the IncX3 plasmid,
was first identified in the IncX3 plasmid (Göttig et al., 2013).
It is noteworthy that a quite systematized alliance with
other antibiotic resistance determinants has been observed
in almost all NDM producers. The additional antimicrobial
resistance genes for plasmid-mediated AmpC cephalosporinases,
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CTX-M-type ESBLs, and 16S RNA methyltransferases have
enhanced the MDR of NDM producers. This strategy
has facilitated the persistence of pathogens that have
encountered combination antimicrobial therapies in clinical
settings.
Clonal dissemination played a major role in the dissemination
of NDM producers in South Korea and the IncX3 plasmid
possessing the blaNDM gene collaborated for the gene spread,
at least among the entirely sequenced strains. NDM producers
pose a major healthcare risk since the isolates are usually
MDR, and the plasmids are frequently transferable to a
wide range of Gram-negative bacteria. This time-course
observation of the genomic epidemiology of NDM has warned
us of the great public health threat of NDM producers,
raising the importance of national policy to combat drug
resistance.
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